| Literature DB >> 35479864 |
Natarajan Sisubalan1, Chandrasekaran Karthikeyan2,3, Venugopal Senthil Kumar3, Kokkarachedu Varaprasad2, Abdulrahman Syed Ahamed Haja Hameed4, Ramar Vanajothi5, Rotimi Sadiku6.
Abstract
Mishandling of antibiotics often leads to the development of multiple drug resistance (MDR) among microbes, resulting in the failure of infection treatments and putting human health at great risk. As a response, unique nanomaterials with superior bioactivity must be developed to combat bacterial infections. Herein, CeO2-based nanomaterials (NMs) were synthesized by employing cerium(iii) nitrate and selective alkaline ions. Moreover, the influence of alkaline ions on CeO2 was investigated, and their characteristics, viz.: biochemical, structural, and optical properties, were altered. The size of nano Ba-doped CeO2 (BCO) was ∼2.3 nm, relatively smaller than other NMs and the antibacterial potential of CeO2, Mg-doped CeO2 (MCO), Ca-doped CeO2 (CCO), Sr-doped CeO2 (SCO), and Ba-doped CeO2 (BCO) NMs against Streptococcus mutans (S. mutans) and Staphylococcus aureus (S. aureus) strains was assessed. BCO outperformed all NMs in terms of antibacterial efficacy. In addition, achieving the enhanced bioactivity of BCO due to reduced particle size facilitated the easy penetration into the bacterial membrane and the presence of a sizeable interfacial surface. In this study, the minimum quantity of BCO required to achieve the complete inhibition of bacteria was determined to be 1000 μg mL-1 and 1500 μg mL-1 for S. mutans and S. aureus, respectively. The cytotoxicity test with L929 fibroblast cells demonstrated that BCO was less toxic to healthy cells. Furthermore, BCO did not show any toxicity and cell morphological changes in the L929 fibroblast cells, which is similar to the control cell morphology. Overall, the results suggest that nano BCO can be used in biomedical applications, which can potentially help improve human health conditions. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35479864 PMCID: PMC9041105 DOI: 10.1039/d1ra05948c
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1(a): XRD patterns of the NMs, and (b) UV-vis reflection spectra of the CeO2, MCO, CCO, SCO, and BCO NMs.
Fig. 2(a–e) The optical bandgap energy of CeO2, MCO, CCO, SCO and BCO NMs, and (f) the schematic of the various forms of CeO2 NPs, showing the UV and visible emission peaks.
Fig. 3PL emission spectra of the (a) CeO2, (b) MCO, (c) CCO, (d) SCO and (e) BCO NMs.
The PL emission values of the CeO2, MCO, CCO, SCO and BCO NMs
| Peak position | CeO2 (nm) | MCO (nm) | CCO (nm) | SCO (nm) | BCO (nm) |
|---|---|---|---|---|---|
| V1 | 399 | 398 | 400 | 397 | 398 |
| V2 | 420 | 419 | 419 | 415 | 418 |
| V3 | 441 | 440 | 440 | 441 | 440 |
| V4 | 451 | 451 | 450 | 450 | 450 |
| V5 | 468 | 468 | 468 | 468 | 468 |
| V6 | 482 | 482 | 482 | 482 | 482 |
| V7 | 492 | 492 | 492 | 492 | 492 |
| V8 | 509 | 508 | 511 | 512 | 513 |
| V9 | 539 | 538 | 539 | 539 | 542 |
Fig. 4(a–e) FESEM images and (a1–e1) EDX spectra of the CeO2, MCO, CCO, SCO and BCO NMs.
Elemental composition of the CeO2, MCO, CCO, SCO and BCO NMs
| Nanomaterials | Atomic% | |||
|---|---|---|---|---|
| Ce | O | Doping amount | Total | |
| CeO2 | 36.80 | 63.20 | — | 100% |
| MCO | 39.90 | 58.54 | 1.56 | 100% |
| CCO | 49.30 | 48.05 | 2.64 | 100% |
| SCO | 26.46 | 72.47 | 1.06 | 100% |
| BCO | 24.59 | 73.57 | 1.84 | 100% |
Fig. 5Fourier transform infrared spectra of the CeO2, MCO, CCO, SCO and BCO NMs.
Fig. 6The mechanism underlying ROS production in the BCO NMs in response to light irradiation.
The antibacterial mechanism of CeO2 NMs with different doping materials against various bacterial strains
| Nanomaterials | Bacterial name | Mechanism |
|---|---|---|
| Au@CeO2 |
| The near-infrared light could significantly enhance the antibacterial activity of Au@CeO2, and the photothermal effect did not dominate the enhancement[ |
| Ce(Mn, Fe)O2 |
| The zone of inhibition (antibacterial effect) increased with an increase in the concentration of the dopant (Mn, Fe) elements[ |
| CeO2/GO |
| CeO2/GO showed the highest values; this confirmed that the interaction of GO and CeO2 as a nanocomposite enhanced the antibacterial activity[ |
| Sm-doped CeO2 |
| The antibacterial activity revealed that the killing efficiency of Sm-CeO2 increased with an increasing concentration of Sm3+[ |
| CeO2–Al2O3 |
| ROS generation led to cell membrane disruption, protein denaturation, and DNA losses, hindering bacterial growth[ |
| Co-doped CeO2 |
| The electrostatic interactions between the positively charged nanomaterial and negatively charged bacteria aided the nanomaterial to penetrate the cell wall and cause damage[ |
| CeO2 |
| The microorganism reduction in viable number indicates loss of inhibition ability of CeO2 nanomaterials[ |
| CeO2/CePO4 |
| The redox switching between Ce3+ and Ce4+ in the CeO2/CePO4 nanocomposites might increase the penetrating ability of the positively charged nanocomposites through the negatively charged bacterial cell wall, causing bacterial cell damage[ |
| Polyindole/Ag–CeO2 |
| The improved antibacterial activity of the nanocomposites based on the concentration of silver ions was due to the interaction between the cell wall of the bacteria and the nanocomposites, which caused toxicity[ |
| Zr-doped CeO2 |
| The antibacterial activity/sensitivity of the nanoparticles was associated with the different bacterial cell wall structures[ |
Fig. 7(I) The antibacterial activity (zone of inhibition) of the NMs against Streptococcus mutans and Staphylococcus aureus. (II) The gradual antibacterial efficiency of the CeO2, MCO, CCO, SCO and BCO NMs toward (a) Streptococcus mutans and (b) Staphylococcus aureus. (III) The CeO2, MCO, CCO, SCO and BCO NMs were screened for antioxidant activity against DPPH-radical scavenging activity. (IV(a and b)) Photo images (20× magnification) reveal the topographical changes seen in the L929 fibroblast cells. (c) Toxicity tests on L929 fibroblast cells treated for 24 hours with various concentrations of BCO NMs (2.5–15 g mL−1).
The MIC and MBC values of SCO and BCO against S. mutans and S. aureus
| Compound |
|
| ||
|---|---|---|---|---|
| MIC (mg mL−1) | MBC (mg mL−1) | MIC (mg mL−1) | MBC (mg mL−1) | |
| SCO | 1 | 1.5 | 1 | 2 |
| BCO | 0.6 | 1 | 0.8 | 1.5 |